5,956 reports of this reaction
2.3% of all BISOPROLOL FUMARATE reports
#6 most reported adverse reaction
DIZZINESS is the #6 most commonly reported adverse reaction for BISOPROLOL FUMARATE, manufactured by TruPharma, LLC. There are 5,956 FDA adverse event reports linking BISOPROLOL FUMARATE to DIZZINESS. This represents approximately 2.3% of all 256,068 adverse event reports for this drug.
Patients taking BISOPROLOL FUMARATE who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for BISOPROLOL FUMARATE, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for BISOPROLOL FUMARATE:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 5,956 FDA reports for BISOPROLOL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 2.3% of all adverse event reports for BISOPROLOL FUMARATE, making it a notable side effect.
If you experience dizziness while taking BISOPROLOL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.